Universal Corporation UVV Q1 2026 Results Miss Estimates EPS 132 vs 194 Omada Health OMDA Q1 2026 Earnings 005 EPS Surges Past 008 Estimates MIND CTI Ltd MNDO Edges Higher Support Holds Near 086 Amid Modest Gains Singapore Strengthens AI Hub Status with Strategic Pacts Involving Google and OpenAI plus 234 Million Commitment Rajnandini Fashion India IPO Sees Strong Day One Subscription Led by Institutional Investors Barclays Analyzes Market Implications of Embodied AI Bullish or Bearish UK Exports to US Slump 25 Following Trumps Liberation Day Tariffs Trade Deficit Emerges SpaceX Successfully Launches Massive Starship V3 Rocket on Test Flight Deutsche Bank Maintains Positive Stance on Salesforce as Citi Adjusts Price Target Lower Wes Streeting Proposes Capital Gains Tax Reforms as Part of Labour Leadership Pitch Nomura Holdings Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution Wintrust Financial WTFCN Q1 2026 Earnings Solid EPS Beat Driven by Strong Net Interest Income AUR Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline STRC Q1 2026 Earnings Massive EPS Miss Highlights Challenges for Preferred Stock Fidelis Insurance Holdings FIHL Slips Slightly Testing Support Levels ZoomInfo GTM Slides 3 Key Support Levels Under Scrutiny NuCana NCNA Holds Near Support After Marginal Decline NeoGenomics NEO Gains 132 as Stock Bounces from Support Eyes Resistance UK Police Chiefs Propose Blocking Unsafe Social Media for Under16s Potential Regulatory Shift GMAB Q1 2026 Earnings EPS Falls Short of Estimates as Stock Eases Lower Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported Bain Capital Specialty Finance Inc BCSF Q1 2026 Earnings Net Investment Income Misses Estimates Stock Edges Higher GLIBK Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Drops MSGE Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher AVTR Q1 2026 Earnings EPS Beats Estimates Stock Rises CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase INTA Q1 2026 Earnings Narrow EPS Beat Highlights Operational Discipline Amid Market Caution